| Dr Michelle Elaine Mark, MD | |
|
1611 W Harrison St Ste 550, Chicago, IL 60612-4861 | |
| (312) 563-4409 | |
| Not Available |
| Full Name | Dr Michelle Elaine Mark |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Location | 1611 W Harrison St Ste 550, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457912123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 125.074920 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Elaine Mark, MD 1611 W Harrison St Ste 550, Chicago, IL 60612-4861 Ph: () - | Dr Michelle Elaine Mark, MD 1611 W Harrison St Ste 550, Chicago, IL 60612-4861 Ph: (312) 563-4409 |
News Archive
A specific and remarkably small fragment of RNA appears to protect rats against cocaine addiction-and may also protect humans, according to a recent study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the journal Nature.
Arizona consumers and businesses can expect to collect more than $36 million in refunds this summer from health-insurance companies under new provisions of the nation's health care law, according to two reports.
More than 15 years ago Edward Stricker and Joseph Verbalis reported that oxytocin (OT) is involved in the neural control of food and salt intake in adult rats. Linda Rinaman at the University of Pittsburgh is investigating the anatomical organization of this system, and also is taking a developmental approach to determine how OT modulates eating and digestion.
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
› Verified 2 days ago
Dr. Mausumi Natalie Syamal, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1611 W Harrison St, Chicago, IL 60612 Phone: 312-563-4100 | |
Laura Anna Petrauskas, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5841 S Maryland Ave # Mc1035, Chicago, IL 60637 Phone: 630-254-6305 | |
Dr. Whitney E. Liddy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 676 N Saint Clair St, Suite 15-200, Chicago, IL 60611 Phone: 312-695-4679 | |
Robert Kern, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Elias M Michaelides, M. D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1611 W Harrison St Ste 550, Chicago, IL 60612 Phone: 312-942-6100 | |
Dr. Stephen Yeh Jr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3860 West Ogden Avenue, Chicago, IL 60623 Phone: 872-588-3000 Fax: 847-998-0483 | |
Aimee Adair Kennedy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Mc 1035, E-102, Chicago, IL 60637 Phone: 773-795-3158 |